All Articles

Identity, a boutique PR firm, just won top honors for the Little Debbie Ice Cream launch. Here’s how they turned childhood memories into a retail empire.

Marketwire's founders are back to disrupt PR with MediaClaw, a new agentic AI platform promising to automate everything from media pitching to SEC compliance.

Quantum X Labs claims a 21-fold error reduction on IBM processors, but can a hybrid company balancing ad tech and quantum deliver on its promises?

As NEXT Properties extends its debt to 2056, the Mexican real estate giant reveals the push-and-pull of green financing amid a historic nearshoring boom.

Cyrano Therapeutics reports positive Phase 2 data for a repurposed asthma drug to treat post-viral smell loss, but regulatory hurdles loom for Phase 3.

With positive Phase 3 data and an FDA review underway, a novel copper IUD aims to double its lifespan while navigating strict new provider safety mandates.

As eQ Plc prepares its Q3 2026 report, we examine how the EUR 14.3 billion asset manager navigates market volatility, M&A health, and the human side of finance.

Despite recent clinical setbacks, Alector's $75 million premium offering signals strong institutional faith in its blood-brain barrier technology.

CNB Community Bancorp's Q3 results highlight a dual reality: operational strength shielding against commercial real estate fractures in the heartland.

As GLP-1 weight-loss drugs reshape consumption, Daesang Corporation's 450% allulose sales surge signals a massive shift in the industrial food supply chain.

As tin prices surge, Metals X’s 15p bid for First Tin tests the defenses of minority shareholders right before a major permitting milestone.

As generative AI hype floods healthcare, Artera’s recent accolades prove that deep EHR integration and agentic workflows truly drive patient access.

With breast cancer rates rising among young women, a gamified digital health app is empowering patients to overcome medical age bias and demand early care.

Adial Pharmaceuticals appoints the architect behind the first FDA-approved AhR agonist to lead its new ulcerative colitis drug into 2027 clinical trials.

As Nigeria pushes toward a 70% local content mandate in its energy sector, indigenous engineering firms are proving that true industrial power lies in human capital.

As global diesel inventories hit decade lows, a structural refining bottleneck is minting billions for energy majors while threatening global supply chains.

By bringing on a veteran dealmaker with deep isotope supply chain expertise, Actinium is positioning its Ac-225 pipeline for big pharma's aggressive M&A wave.

Days before a historic provincial vote, sudden polling changes in remote Indigenous communities raise critical questions about democratic infrastructure and economic stability.

STS Digital’s recent Euromoney award highlights a strategic shift in digital assets, where institutional-grade infrastructure and TradFi parity are essential.

Regions Financial’s Q3 2026 results reveal how a disciplined hedging strategy and record fee income are redefining regional bank resilience.